SKI Market

A+| A| A-| Skip to Main Content

Indian Indices

Sensex

81,592.45 -318.56
( -0.39%)

Global Indices

Nasdaq

52,431.30 -76.19
(-0.15%)

Dow Jones

7,621.14 -19.24
(-0.25%)

Hang Seng

61,109.24 289.88
(0.48%)

Nikkei 225

10,863.06 27.59
(0.25%)

Forex

USD-INR

93.72 0.15
(0.16%)

EUR-INR

104.27 -0.51
(-0.49%)

GBP-INR

124.72 -0.66
(-0.52%)

JPY-INR

0.59 0.00
(-0.43%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Cipla Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

500087

INE059A01026

432.1356994

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

CIPLA

39.89

113912.22

EPS(TTM)

Face Value()

Div & Yield %

35.35

0.92

Back

Gallantt Ispat consolidated net profit declines 31.96% in the September 2026 quarter

Oct 21,2026

Net profit of Gallantt Ispat declined 31.96% to Rs 60.51 crore in the quarter ended September 2026 as against Rs 88.93 crore during the previous quarter ended September 2025. Sales rose 13.15% to Rs 1145.89 crore in the quarter ended September 2026 as against Rs 1012.75 crore during the previous quarter ended September 2025.

Particulars	Quarter Ended
	Sep. 2026	Sep. 2025	% Var.
Sales	1145.89	1012.75	13
OPM %	9.57	12.99	-
PBDT	118.68	135.67	-13
PBT	83.17	103.01	-19
NP	60.51	88.93	-32

81,592.45 -318.56 ( -0.39%)

52,431.30 -76.19 (-0.15%)

7,621.14 -19.24 (-0.25%)

61,109.24 289.88 (0.48%)

10,863.06 27.59 (0.25%)

93.72 0.15 (0.16%)

104.27 -0.51 (-0.49%)

124.72 -0.66 (-0.52%)

0.59 0.00 (-0.43%)